AVT-001

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAVT-001

Drug Alias NameAVT-001

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsDiabetes Mellitus, Type 1

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesAvotres Inc

China Registration ClassN/A

Develop Information

Active CompaniesAvotres Inc

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus, Type 1

Inactive IndicationsN/A

Other Information

ATC CodeN/A